Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Interest & Investment Income (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Interest & Investment Income for 2 consecutive years, with $242000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income fell 94.93% to $242000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.1 million, a N/A change, with the full-year FY2024 number at $930000.0, down 49.51% from a year prior.
  • Interest & Investment Income was $242000.0 for Q3 2025 at Pyxis Oncology, down from $995000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $4.8 million in Q3 2024 to a low of -$4.5 million in Q4 2024.